The Food and Drug Administration (FDA) announced that it is considering allowing the use of amphetamine-like drug fenfluramine to treat forms of epilepsy that are otherwise difficult to treat and resistant to traditional anti-epileptic drugs.
Amphetamine-like substances are banned in Taiwan, with the import, manufacture and sale of fenfluramine prohibited in 1980, when all licenses for its use were revoked, Medicinal Product Division deputy head Lin Yi-chu (林意筑) said today.
The FDA, under the Ministry of Health and Welfare (MOHW), on Tuesday announced draft revisions to the regulations on amphetamine-like substances and their derivatives, with a 14-day window for public comment.
Photo: Chung Li-hua, Taipei Times
Fenfluramine was previously used for weight loss, with many countries removing it from the market following clinical trials that showed it can cause side effects, including valvular heart disease, Lin said.
However, research has shown that controlled use of the drug is effective in treating Dravet Syndrome and Lennox-Gastaut Syndrome, rare forms of epilepsy otherwise difficult to treat, she said.
Since 2020, the US, Europe and Japan have gradually approved it for controlled use, she added.
Repeated seizures can hinder normal development and cause neurological impairments, leading to a higher mortality rate and impacting the quality of life of caregivers, she said.
Several organizations in Taiwan, including the Taiwan Foundation for Rare Disorders, the Taiwan Epilepsy Association and the Taiwan Child Neurology Society, have petitioned that the FDA approve the use of fenfluramine, she said.
After consulting medical societies and medical professionals, the FDA is considering approving fenfluramine and its salt to treat these two rare syndromes, she said.
Amphetamine-like drugs are central nervous system stimulants that may cause symptoms such as restlessness, dizziness, tremors, hyperactivity, insomnia, anxiety and delirium, the draft regulation said.
They are also addictive and can cause increased tolerance in patients, it said.
Amphetamine-like substances would still be strictly controlled under the Pharmaceutical Affairs Act (藥事法), including amphetamine, dexamphetamine, methamphetamine, phendimetrazine, diethylpropione and fenfluramine, it said.
A magnitude 6.1 earthquake struck off the coast of Yilan County at 8:39pm tonight, the Central Weather Administration (CWA) said, with no immediate reports of damage or injuries. The epicenter was 38.7km east-northeast of Yilan County Hall at a focal depth of 98.3km, the CWA’s Seismological Center said. The quake’s maximum intensity, which gauges the actual physical effect of a seismic event, was a level 4 on Taiwan’s 7-tier intensity scale, the center said. That intensity level was recorded in Yilan County’s Nanao Township (南澳), Hsinchu County’s Guansi Township (關西), Nantou County’s Hehuanshan (合歡山) and Hualien County’s Yanliao (鹽寮). An intensity of 3 was
Instead of focusing solely on the threat of a full-scale military invasion, the US and its allies must prepare for a potential Chinese “quarantine” of Taiwan enforced through customs inspections, Stanford University Hoover fellow Eyck Freymann said in a Foreign Affairs article published on Wednesday. China could use various “gray zone” tactics in “reconfiguring the regional and ultimately the global economic order without a war,” said Freymann, who is also a nonresident research fellow at the US Naval War College. China might seize control of Taiwan’s links to the outside world by requiring all flights and ships entering or leaving Taiwan
The first of 10 new high-capacity trains purchased from South Korea’s Hyundai Rotem arrived at the Port of Taipei yesterday to meet the demands of an expanding metro network, Taipei Rapid Transit Corp (TRTC) said yesterday. The train completed a three-day, 1,200km voyage from the Port of Masan in South Korea, the company said. Costing NT$590 million (US$18.79 million) each, the new six-carriage trains feature a redesigned interior based on "human-centric" transportation concepts, TRTC said. The design utilizes continuous longitudinal seating to widen the aisles and optimize passenger flow, while also upgrading passenger information displays and driving control systems for a more comfortable
Taiwan's first indigenous defense submarine, the SS-711 Hai Kun (海鯤, or Narwhal), departed for its 13th sea trial at 7am today, marking its seventh submerged test, with delivery to the navy scheduled for July. The outing also marked its first sea deployment since President William Lai (賴清德) boarded the submarine for an inspection on March 19, drawing a crowd of military enthusiasts who gathered to show support. The submarine this morning departed port accompanied by CSBC Corp’s Endeavor Manta (奮進魔鬼魚號) uncrewed surface vessel and a navy M109 assault boat. Amid public interest in key milestones such as torpedo-launching operations and overnight submerged trials,
RSS